§ 20-1004. Duties and responsibilities of Office
West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2021
Effective: October 1, 2021
MD Code, Health - General, § 20-1004
§ 20-1004. Duties and responsibilities of Office
The Office shall:
(1) Be an advocate for the improvement of minority health care by working with the Department on its own, or in partnership with other public and private entities to establish appropriate forums, programs, or initiatives designed to educate the public regarding minority health and health disparities issues, with an emphasis on preventive health and healthy lifestyles;
(7) Obtain funding and, contingent upon funding, provide grants to community-based organizations and historically black colleges and universities to conduct special research, demonstration, and evaluation projects for targeted at-risk racial and ethnic minority populations and to support ongoing community-based programs that are designed to reduce or eliminate racial and ethnic health disparities in the State;
(15) Work collaboratively with universities and colleges of medicine, nursing, pharmacy, dentistry, social work, public health, and allied health in this State and other health care professional training programs to develop courses with cultural competency, sensitivity, and health literacy, that are designed to address the problem of racial and ethnic disparities in health care access, utilization, treatment decisions, quality, and outcomes;
(16) Work collaboratively with the Maryland Health Care Disparities Initiative, the Morgan-Hopkins Center for Health Disparities Solutions, the University of Maryland Disparity Project, the Monumental City Medical Society, faculty and researchers at historically black colleges and universities, and other existing alliances or plans, to reduce or eliminate racial and ethnic disparities in the State;
(17) Seek to establish a statewide alliance with community-based agencies and organizations, historically black colleges and universities, health care facilities, health care provider organizations, managed care organizations, and pharmaceutical manufacturers to promote the objectives of the Office;
Credits
Added by Acts 2004, c. 319, § 1, eff. Oct. 1, 2004; Acts 2004, c. 443, § 1, eff. Oct. 1, 2004. Amended by Acts 2006, c. 44, § 1, eff. April 8, 2006; Acts 2006, c. 450, § 1, eff. Oct. 1, 2006; Acts 2008, c. 675, § 1, eff. July 1, 2008; Acts 2012, c. 671, § 1, eff. July 1, 2012; Acts 2017, c. 633, § 1, eff. June 1, 2017; Acts 2017, c. 634, § 1, eff. June 1, 2017; Acts 2018, c. 12, § 1, eff. April 5, 2018; Acts 2021, c. 744, § 1, eff. Oct. 1, 2021; Acts 2021, c. 745, § 1, eff. Oct. 1, 2021; Acts 2021, c. 761, § 1, eff. Oct. 1, 2021; Acts 2021, c. 762, § 1, eff. Oct. 1, 2021.
MD Code, Health - General, § 20-1004, MD HEALTH GEN § 20-1004
Current with all legislation from the 2023 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |